Mölne Diagnostik och Utbildning
Mölne Diagnostik och Utbildning is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
A Phase 3 open-label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in the treatment of severe anti-GBM antibody disease (Goodpasture disease)
Sponsor Hansa Biopharma AB
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Mölne Diagnostik och Utbildning?
The 2026-10-09 snapshot links Mölne Diagnostik och Utbildning to 1 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Mölne Diagnostik och Utbildning?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Mölne Diagnostik och Utbildning conducted?
The linked trials record locations in 12 countries, including Austria, Belgium, Czechia, Germany, Denmark. These are trial locations, not confirmed office locations or countries where Mölne Diagnostik och Utbildning delivered services.
What can this page tell me about Mölne Diagnostik och Utbildning's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Mölne Diagnostik och Utbildning. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Mölne Diagnostik och Utbildning AB